Bicyclic heterocycles as HIV integrase inhibitors
US7157447B2 · kind B2 · utility
11Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2005 |
| Grant date | Jan 2, 2007 |
| Priority date | — |
| Expiry date | Nov 29, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.